Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00016367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: Trastuzumab
DRUG: Cisplatin
DRUG: Gemcitabine Hydrochloride

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]